194 related articles for article (PubMed ID: 24639549)
1. Therapeutic vaccine against DPP4 improves glucose metabolism in mice.
Pang Z; Nakagami H; Osako MK; Koriyama H; Nakagami F; Tomioka H; Shimamura M; Kurinami H; Takami Y; Morishita R; Rakugi H
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):E1256-63. PubMed ID: 24639549
[TBL] [Abstract][Full Text] [Related]
2. A novel multi-epitope vaccine based on Dipeptidyl Peptidase 4 prevents streptozotocin-induced diabetes by producing anti-DPP4 antibody and immunomodulatory effect in C57BL/6J mice.
Li Z; Fang J; Jiao R; Wei X; Ma Y; Liu X; Cheng P; Li T
Biomed Pharmacother; 2017 May; 89():1467-1475. PubMed ID: 28376584
[TBL] [Abstract][Full Text] [Related]
3. Construction of a novel vaccine by conjugating a B-cell epitope of DPP4 to peptide IA2(5)-P2-1 to significantly control type 1 diabetes in NOD mice.
Li Y; Cao H; Li Y; Li Z; Wei X; Jiao R; Cheng P; Liu X; Ma Y; Xing Y; Tang J; Wang M; Li T
Vaccine; 2017 Dec; 35(51):7187-7197. PubMed ID: 29169891
[TBL] [Abstract][Full Text] [Related]
4. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
Klemann C; Wagner L; Stephan M; von Hörsten S
Clin Exp Immunol; 2016 Jul; 185(1):1-21. PubMed ID: 26919392
[TBL] [Abstract][Full Text] [Related]
5. Biological function of dipeptidyl peptidase-4 on type 2 diabetes patients and diabetic mice.
Qiao J; Li L; Ma Y; Shi R; Teng M
Curr Res Transl Med; 2019 Aug; 67(3):89-92. PubMed ID: 30591375
[TBL] [Abstract][Full Text] [Related]
6. Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes.
Kim TH; Kim MK; Cheong YH; Chae YN; Lee Y; Ka SO; Jung IH; Shin CY; Bae EJ; Son MH
Eur J Pharmacol; 2016 Jan; 771():65-76. PubMed ID: 26621343
[TBL] [Abstract][Full Text] [Related]
7. Adipose-derived stromal cells reverse insulin resistance through inhibition of M1 expression in a type 2 diabetes mellitus mouse model.
Chen LW; Chen PH; Tang CH; Yen JH
Stem Cell Res Ther; 2022 Jul; 13(1):357. PubMed ID: 35883204
[TBL] [Abstract][Full Text] [Related]
8. DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes.
Kim MK; Chae YN; Kim HD; Yang EK; Cho EJ; Choi SH; Cheong YH; Kim HS; Kim HJ; Jo YW; Son MH; Kim SH; Shin CY
Life Sci; 2012 Jan; 90(1-2):21-9. PubMed ID: 22056373
[TBL] [Abstract][Full Text] [Related]
9. A Novel Multi-Epitope Vaccine Based on Urate Transporter 1 Alleviates Streptozotocin-Induced Diabetes by Producing Anti-URAT1 Antibody and an Immunomodulatory Effect in C57BL/6J Mice.
Ma Y; Cao H; Li Z; Fang J; Wei X; Cheng P; Jiao R; Liu X; Li Y; Xing Y; Tang J; Jin L; Li T
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29035321
[TBL] [Abstract][Full Text] [Related]
10. A siRNA mediated hepatic dpp4 knockdown affects lipid, but not glucose metabolism in diabetic mice.
Görgens SW; Jahn-Hofmann K; Bangari D; Cummings S; Metz-Weidmann C; Schwahn U; Wohlfart P; Schäfer M; Bielohuby M
PLoS One; 2019; 14(12):e0225835. PubMed ID: 31794591
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans.
Baggio LL; Varin EM; Koehler JA; Cao X; Lokhnygina Y; Stevens SR; Holman RR; Drucker DJ
Nat Commun; 2020 Jul; 11(1):3766. PubMed ID: 32724076
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting adipose tissue M1 cytokine expression decreases DPP4 activity and insulin resistance in a type 2 diabetes mellitus mouse model.
Chen LW; Chen PH; Yen JH
PLoS One; 2021; 16(5):e0252153. PubMed ID: 34043673
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase inhibitor therapy in type 2 diabetes: Control of the incretin axis and regulation of postprandial glucose and lipid metabolism.
Mulvihill EE
Peptides; 2018 Feb; 100():158-164. PubMed ID: 29412815
[TBL] [Abstract][Full Text] [Related]
14. Intestinal Sodium Glucose Cotransporter 1 Inhibition Enhances Glucagon-Like Peptide-1 Secretion in Normal and Diabetic Rodents.
Oguma T; Nakayama K; Kuriyama C; Matsushita Y; Yoshida K; Hikida K; Obokata N; Tsuda-Tsukimoto M; Saito A; Arakawa K; Ueta K; Shiotani M
J Pharmacol Exp Ther; 2015 Sep; 354(3):279-89. PubMed ID: 26105952
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide.
Long Z; Cao M; Su S; Wu G; Meng F; Wu H; Liu J; Yu W; Atabai K; Wang X
Free Radic Biol Med; 2017 Dec; 113():71-83. PubMed ID: 28942246
[TBL] [Abstract][Full Text] [Related]
16. miR-548ag promotes DPP4 expression in hepatocytes through activation of TLR(7/8)/NF-κB pathway.
Xiong J; Sun C; Wen X; Hou Y; Liang M; Liu J; Wei Q; Yuan F; Peng C; Chen Y; Chang Y; Wang C; Zhang J
Int J Obes (Lond); 2024 Jul; 48(7):941-953. PubMed ID: 38424257
[TBL] [Abstract][Full Text] [Related]
17. Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis.
Mulvihill EE; Varin EM; Gladanac B; Campbell JE; Ussher JR; Baggio LL; Yusta B; Ayala J; Burmeister MA; Matthews D; Bang KWA; Ayala JE; Drucker DJ
Cell Metab; 2017 Jan; 25(1):152-165. PubMed ID: 27839908
[TBL] [Abstract][Full Text] [Related]
18. Effects of combination therapy with vildagliptin and valsartan in a mouse model of type 2 diabetes.
Miyagawa K; Kondo T; Goto R; Matsuyama R; Ono K; Kitano S; Kawasaki S; Igata M; Kawashima J; Matsumura T; Motoshima H; Araki E
Cardiovasc Diabetol; 2013 Nov; 12():160. PubMed ID: 24188631
[TBL] [Abstract][Full Text] [Related]
19. Prediabetes blunts DPP4 genetic control of postprandial glycaemia and insulin secretion.
Patarrão RS; Duarte N; Coelho I; Ward J; Ribeiro RT; Meneses MJ; Andrade R; Costa J; Correia I; Boavida JM; Duarte R; Gardete-Correia L; Medina JL; Pell J; Petrie J; Raposo JF; Macedo MP; Penha-Gonçalves C
Diabetologia; 2022 May; 65(5):861-871. PubMed ID: 35190847
[TBL] [Abstract][Full Text] [Related]
20. Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice.
Sauvé M; Ban K; Momen MA; Zhou YQ; Henkelman RM; Husain M; Drucker DJ
Diabetes; 2010 Apr; 59(4):1063-73. PubMed ID: 20097729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
